Skip to content

IP License - Prognostic Gene Signature and Method for Diffuse Large B-Cell Lymphoma Prognosis and Treatment

IP Licensing
Availability: Available On Demand

For informational purposes only. Please contact seller directly for more details.

Share This:

Systems, treatment and prognostic methods, and kits for risk stratification and development of treatment options for diffuse large B-cell lymphoma patients. The systems, methods, and kits comprise determining, detecting, and evaluating gene expression values for a defined gene panel, or a subset thereof, detected in a biological sample from the patient and determining a risk score associated with the gene signature panel, which can be used to guide treatment of the patient.

Shipping Information

Digital delivery/downloads will typically be delivered within 2 business days.

Physical products typically take 5-8 business days. Please contact the seller directly with any questions about your order.

You will receive an order confirmation email from PedsMrkt followed by a shipping email when your order ships.

Returns

Please contact the seller directly for their return policy and to
handle returns. Customer will be responsible for return shipping fees.